JPH03505332A - リウマトイド関節炎などの自己免疫性疾病の治療に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体 - Google Patents

リウマトイド関節炎などの自己免疫性疾病の治療に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体

Info

Publication number
JPH03505332A
JPH03505332A JP2505759A JP50575990A JPH03505332A JP H03505332 A JPH03505332 A JP H03505332A JP 2505759 A JP2505759 A JP 2505759A JP 50575990 A JP50575990 A JP 50575990A JP H03505332 A JPH03505332 A JP H03505332A
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
group
tables
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2505759A
Other languages
English (en)
Japanese (ja)
Inventor
ドリア，ジアンフエデリコ
イセツタ，アンナ・マリア
フエレツチオ，リナルド
フエラリ，マリオ
フルナシエロ，マリア・キアラ
トリツイオ，ドメニコ
Original Assignee
フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ filed Critical フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ
Publication of JPH03505332A publication Critical patent/JPH03505332A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2505759A 1989-04-06 1990-04-04 リウマトイド関節炎などの自己免疫性疾病の治療に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体 Pending JPH03505332A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8907799.4 1989-04-06
GB898907799A GB8907799D0 (en) 1989-04-06 1989-04-06 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases

Publications (1)

Publication Number Publication Date
JPH03505332A true JPH03505332A (ja) 1991-11-21

Family

ID=10654581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2505759A Pending JPH03505332A (ja) 1989-04-06 1990-04-04 リウマトイド関節炎などの自己免疫性疾病の治療に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体

Country Status (15)

Country Link
US (2) US5196445A (de)
EP (1) EP0423269B1 (de)
JP (1) JPH03505332A (de)
KR (1) KR920700031A (de)
AT (1) ATE99934T1 (de)
AU (1) AU5416990A (de)
CA (1) CA2030530A1 (de)
DD (1) DD298478A5 (de)
DE (1) DE69005974T2 (de)
GB (1) GB8907799D0 (de)
HU (1) HUT58518A (de)
IL (1) IL93989A0 (de)
PT (1) PT93680A (de)
WO (1) WO1990011760A1 (de)
ZA (1) ZA902649B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695547B1 (de) * 1993-04-09 2001-08-08 Toyama Chemical Co., Ltd. Immunomodulator, zelladhäsionsinhibitor und mittel zur behandlung und vorbeugung von autoimmunerkrankungen
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
CA2229479C (en) * 1995-08-15 2010-03-30 Connective Therapeutics, Inc. Method of promoting angiogenesis
US7285422B1 (en) * 1997-01-23 2007-10-23 Sequenom, Inc. Systems and methods for preparing and analyzing low volume analyte array elements
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
GB9720901D0 (en) * 1997-10-01 1997-12-03 Pharmacia & Upjohn Spa Condensed benzothiopyranic compounds
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
EP1395226A4 (de) * 2001-06-11 2005-03-30 Univ Miami Verwendung von radiopharmazeutischen komplexen zur verbesserung der transplantationstoleranz
EP1444207A2 (de) * 2001-09-19 2004-08-11 Pharmacia Corporation Substituierte pyrazolylverbindungen zur behandlung von entzündungen
ATE363473T1 (de) * 2001-09-19 2007-06-15 Pharmacia Corp Substituierte pyrazoloverbindungen zur behandlung von entzündungen
US20050116027A1 (en) * 2003-06-12 2005-06-02 First Data Corp. Personalized presentation instrument production systems and methods
EA201290305A1 (ru) * 2009-11-13 2012-12-28 Мерк Сероно С.А. Производные трициклического пиразоламина

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4173634A (en) * 1979-02-23 1979-11-06 E. R. Squibb & Sons, Inc. Basically-substituted tricyclic pyrazoles useful as antiinflammatory agents
JPS57109787A (en) * 1980-12-26 1982-07-08 Chugai Pharmaceut Co Ltd Pyrazoloindazole derivative
US4816467A (en) * 1987-01-09 1989-03-28 Farmitalia Carlo Erba S.R.L Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use
US4853405A (en) * 1987-01-21 1989-08-01 Farmitalia Carlo Erba S.R.L. Condensed pyrazole derivatives, pharmaceutical compositions and use
GB8814586D0 (en) * 1988-06-20 1988-07-27 Erba Carlo Spa Tricyclic 3-oxo-propanenitrile derivatives & process for their preparation
GB8814587D0 (en) * 1988-06-20 1988-07-27 Erba Carlo Spa Condensed pyrazole 3-oxo-propanenitrile derivatives & process for their preparation
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents
GB2227741B (en) * 1989-02-06 1992-08-05 Erba Carlo Spa Condensed 3-oxo-propanenitrile derivatives and process for their preparation

Also Published As

Publication number Publication date
WO1990011760A1 (en) 1990-10-18
AU5416990A (en) 1990-11-05
CA2030530A1 (en) 1990-10-07
ZA902649B (en) 1991-01-30
EP0423269B1 (de) 1994-01-12
DE69005974D1 (de) 1994-02-24
EP0423269A1 (de) 1991-04-24
KR920700031A (ko) 1992-02-19
IL93989A0 (en) 1991-01-31
HUT58518A (en) 1992-03-30
DE69005974T2 (de) 1994-05-05
ATE99934T1 (de) 1994-01-15
US5196445A (en) 1993-03-23
GB8907799D0 (en) 1989-05-17
US5352676A (en) 1994-10-04
HU903690D0 (en) 1991-03-28
DD298478A5 (de) 1992-02-27
PT93680A (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
IE58595B1 (en) Use of alfuzosine for the treatment of urinary conditions
JPH03505332A (ja) リウマトイド関節炎などの自己免疫性疾病の治療に有用なヘテロアリール―３―オキソ―プロパンニトリル誘導体
EP3458448B1 (de) Fasn-hemmer zur behandlung der nicht-alkoholischen steatohepatitis
JPH06234635A (ja) インターロイキン１ベータを阻害するためのレフルノミドの使用
EP0434807B1 (de) Heteroaryl-3-oxo-propan-nitril-derivat verwendbar in erregung von myelopoiesis
WO2004098525A2 (en) Uses of ion channel modulating compounds
MX2010012179A (es) Composicion farmaceutica para el tratamiento de eyaculacion prematura.
JPH03251530A (ja) チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
US20250084035A1 (en) Polymorphic form of meisoindigo and modified formulation of meisoindigo
US5260328A (en) Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis
JP4303474B2 (ja) 医薬活性のある化合物及び使用方法
CN114980898A (zh) 用于治疗炎性肠病的方法
JP4104986B2 (ja) 前立腺肥大症に伴う膀胱刺激症状治療剤
RU2058778C1 (ru) Соединение, обладающее противодепрессантным действием
JP2013010776A (ja) 脊髄小脳変性症治療剤
ZA200604025B (en) Phosphodiesterase V inhibitor formulations
US5672610A (en) Methods of increasing macrophage function
JPH02304058A (ja) キサントシリンｘモノメチルエーテル誘導体及びそれを含有する抗腫瘍剤
JPS59231057A (ja) カルボン酸アミド化合物およびその誘導体
GB2177913A (en) Anti malarial compositions
EP0591937A1 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
CN120225201A (zh) 治疗炎症性病状的方法
JPS6229523A (ja) ジベンズ〔ｃｄ，ｆ〕インド−ルの新規用途
JPH041183A (ja) イソオキサゾロン化合物およびその用途
JPH04500375A (ja) 二環式化合物のｎ―イミダゾリル誘導体とサイクロスポリンの医薬上の併用